FindTrial
Sign In

Prognosis of novel coronavirus infection (COVID-19) in patients with inflammatory bowel disease

Prognosis of novel coronavirus infection (COVID-19) in patients with inflammatory bowel disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068121
Enrollment
Unknown
Registered
2023-02-08
Start date
2023-02-08
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

Inflammatory bowel disease group:non
Healthy control group:non

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inflammatory bowel disease group: 1) Patients who have been diagnosed with IBD according to their clinical manifestations, endoscopic examination results and pathological findings; 2) Age =18 years old. Healthy control group: 1) Healthy volunteers without autoimmune diseases; 2) Age =18 years old.

Exclusion criteria

Exclusion criteria: 1) Patients unable to understand the content of the questionnaire and fill in the questionnaire; 2) Patients who refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
Infection rate of novel coronavirus;Symptoms and duration of novel coronavirus infection;—

Countries

China

Contacts

Public ContactYan Zhang

West China Hospital, Sichuan University

hxzyan@163.com18980602066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026